Roche shareholders back full slate of proposals, approve record dividend increase
Pfizer’s experimental atopic dermatitis drug shows strong Phase 2 results
Cirena licenses breakthrough RNA synthesis technology from CU Boulder
Roche reports Phase III persevERA breast cancer trial results
Alcon launches Hydrus Microstent in India to transform glaucoma care
FDA grants priority review to Enhertu for high-risk HER2-positive breast cancer
Bristol Myers Squibb reports positive phase 3 results for oral multiple myeloma therapy
AbbVie reports promising early results for novel obesity therapy ABBV-295
Relmada’s NDV-01 shows strong 12-month results in hard-to-treat bladder cancer
FDA nod to Bristol Myers Squibb’s Sotyktu as new oral therapy for psoriatic arthritis
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1773217467)
